 A year after paying Translate Bio Inc NASDAQ: TBIO a whopping 425 million to develop mRNA vaccines for infectious diseases, including COVID-19, Sanofi SA NASDAQ: SNY has announced a 3.2 billion buyout for Translate Bio. Sanofi will pay 38 in cash for each of Translate Bios shares, a 30 premium to Mondays closing price of 29.15. 